Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Blood Cancer Journal|August 13, 2016
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blastsM Cartellieri, A Feldmann, S Koristka, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 3, 2013
Reduction of health risk factors through an adapted physical activity program in patients with breast cancerA-M Foucaut, S E Berthouze-Aranda, M Touillaud, et al.Journal of Wildlife Diseases|January 29, 2011
Immunogenicity and efficacy of two rabies vaccines in wild-caught, captive raccoonsL J Brown, R C Rosatte, C Fehlner-Gardiner, et al.Infection|September 1, 1995
Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0)P Bachmann, J Beyer, S Brust, et al.Clinical and Experimental Immunology|January 18, 2006
Neo-epitopes are required for immunogenicity of the La/SS-B nuclear antigen in the context of late apoptotic cellsZ-J Pan, K Davis, S Maier, et al.Journal of Magnetic Resonance Imaging : JMRI|February 21, 2003
Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic dataJürgen Machann, Oliver P Bachmann, Klaus Brechtel, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 2, 2012
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptinR Violante, J H A Oliveira, K-H Yoon, et al.Magnetic Resonance in Medicine|February 17, 2001
Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS studyK Brechtel, D B Dahl, J Machann, et al.Cancer Immunology, Immunotherapy : CII|August 16, 2019
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cellsStefanie Koristka, Pauline Ziller-Walter, Ralf Bergmann, et al.Vaccine|March 19, 2013
An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, CanadaK G Sobey, A A Walpole, R Rosatte, et al.Pageof 13